New challenges to renin-angiotensin-system in COVID-19 pandemic

S. Yanev, T. Stoyanova
{"title":"New challenges to renin-angiotensin-system in COVID-19 pandemic","authors":"S. Yanev, T. Stoyanova","doi":"10.14748/BMR.V31.7709","DOIUrl":null,"url":null,"abstract":"In the fight against the global epidemic from the new corona virus (SARS-CoV-2), awareness on the site of the primary viral attack, the so-called „entry port“ enables an implies efficient prophylactic/therapeutic approach The attack is aimed at the important balancing unit of the renin-angiotensin system (RAS), angiotensin-converting enzyme 2 (ACE2), which regulates the level of angiotensin II (Ang II) While Ang II has vasoconstrictor and inflammatory functions, the ACE2 converted product of Ang-(1-7) possesses vasodilating and anti-inflammatory functions In patients with pathological cardiovascular symptoms and increased blood pressure, maintenance of optimal Ang II is achieved by inhibiting the synthesizing enzyme ACE1 or blocking the angiotensin receptor response (ATR) In this Dance Round, an attempt is made to address the question: In the unbalanced functions of RAS (manifesting as an outcome of SARS-CoV-2 epidemic), will the therapeutic effect of ACE1 inhibitors change and in what direction?","PeriodicalId":8906,"journal":{"name":"Biomedical Reviews","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14748/BMR.V31.7709","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the fight against the global epidemic from the new corona virus (SARS-CoV-2), awareness on the site of the primary viral attack, the so-called „entry port“ enables an implies efficient prophylactic/therapeutic approach The attack is aimed at the important balancing unit of the renin-angiotensin system (RAS), angiotensin-converting enzyme 2 (ACE2), which regulates the level of angiotensin II (Ang II) While Ang II has vasoconstrictor and inflammatory functions, the ACE2 converted product of Ang-(1-7) possesses vasodilating and anti-inflammatory functions In patients with pathological cardiovascular symptoms and increased blood pressure, maintenance of optimal Ang II is achieved by inhibiting the synthesizing enzyme ACE1 or blocking the angiotensin receptor response (ATR) In this Dance Round, an attempt is made to address the question: In the unbalanced functions of RAS (manifesting as an outcome of SARS-CoV-2 epidemic), will the therapeutic effect of ACE1 inhibitors change and in what direction?
COVID-19大流行对肾素-血管紧张素系统的新挑战
在抗击新型冠状病毒(SARS-CoV-2)全球流行的斗争中,对主要病毒攻击部位的认识,即所谓的“入口”,可以提供一种潜在的有效预防/治疗方法。攻击的目标是肾素-血管紧张素系统(RAS)的重要平衡单元,血管紧张素转换酶2 (ACE2),它调节血管紧张素II (Ang II)的水平,而Ang II具有血管收缩和炎症功能。在具有病理性心血管症状和血压升高的患者中,通过抑制ACE1合成酶或阻断血管紧张素受体反应(ATR)来维持最佳的Ang II。本文试图解决以下问题:在RAS功能失衡(表现为SARS-CoV-2流行的结果)中,ACE1抑制剂的治疗效果会发生变化吗?方向是什么?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信